Category - Markets

Markets

BTIG cuts Misonix to neutral on proposed acquisition by Bioventus

BTIG downgraded Misonix (NASDAQ:MSON) to “neutral” on a pending acquisition by Bioventus. Under the accord, Misonix shareholders would receive either 1.6839 shares of Bioventus common stock or $28 for each share held...

July 30, 2021

Markets

Cantor halves Ardelyx PT to $7 from $14; maintains OW rating

Cantor Fitzgerald slashed its price target for Ardelyx (NASDAQ:ARDX) to $7 from $14 after the company received a complete response letter from the FDA for its NDA for tenapanor to control serum phosphorus in adult...

July 30, 2021

Markets

Cantor starts Nyxoah at OW; PT $43

Cantor Fitzgerald initiated coverage of Nyxoah SA (NASDAQ:NYXH) with an “overweight” rating and 12-month price target of $43, citing the company’s “pipeline and uniquely differentiated product”. The stock closed at $32...

July 28, 2021

Markets

Canaccord starts CVRx at buy; PT $30

Canaccord Genuity initiated coverage of CVRx (NASDAQ:CVRX) with a “buy” rating and price target of $30. The stock closed at $20.22 on July 23. “We believe that CVRx is uniquely positioned in addressing significant unmet...

July 26, 2021

Markets

Stifel starts Acumen Pharma at buy; PT $27

Stifel launched coverage of Acumen Pharmaceuticals (NASDAQ:ABOS) with a “buy” rating and $27 price target. The stock closed at $17.08 on July 23. Acumen is a biotechnology company focused on the development of a next...

July 26, 2021

Markets

Cantor starts SELLAS Life Sciences at OW; PT $18

Cantor Fitzgerald launched coverage of SELLAS Life Sciences (NASDAQ:SLS) with an “outperform” rating and $18 price target. The stock closed at $8.60 on July 20. SELLAS is a late-stage immune-oncology company that is...

July 21, 2021

Markets

Stifel starts GH Research at buy; PT $26

Stifel launched coverage of GH Research PLC (NASDAQ:GHRS) with a “buy” rating and price target of $26. The stock closed at $17.25 on July 19. “We believe GH offers an attractive way to invest in the psychedelics space...

July 20, 2021

Markets

Analysts start Alpha Teknova at outperform, buy

Analysts for William Blair and BTIG initiated coverage of Alpha Teknova (NASDAQ:TKNO) with “outperform” and “buy” ratings, respectively, citing the company’s exposure to several large, rapidly growing markets. “In...

July 20, 2021

Markets

SVB Leerink starts Elevation Oncology at OP; PT $20

SVB Leerink launched coverage of Elevation Oncology (NASDAQ:ELEV) with an “outperform” rating and $20 price target. The stock closed at $12.10 on July 19. Elevation is a clinical development-stage biotech company...

July 20, 2021

Markets

WB starts Talkspace at outperform

William Blair launched coverage of Talkspace (NASDAQ:TALK) with an “outperform” rating, pointing to the company’s platform and significant market opportunity. The stock closed at $5.81 on July 16. “We believe the...

July 19, 2021

Category - Markets

Subscribe